Robert F. Werner is Chief Accounting Officer of Twist Bioscience Corp. Currently has a direct ownership of 48,454 shares of TWST, which is worth approximately $1.22 Million. The most recent transaction as insider was on Sep 08, 2025, when has been sold 235 shares (Common Stock) at a price of $25.76 per share, resulting in proceeds of $6,053. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.5K
3.03% 3M change
25.13% 12M change
Total Value Held $1.22 Million

ROBERT F. WERNER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 08 2025
SELL
Open market or private sale
$6,053 $25.76 p/Share
235 Reduced 0.48%
48,454 Common Stock
Aug 25 2025
SELL
Open market or private sale
$23,619 $27.69 p/Share
853 Reduced 1.72%
48,689 Common Stock
Aug 21 2025
SELL
Open market or private sale
$6,178 $25.96 p/Share
238 Reduced 0.48%
49,542 Common Stock
Aug 04 2025
SELL
Open market or private sale
$5,274 $28.36 p/Share
186 Reduced 0.37%
49,780 Common Stock
Jun 06 2025
SELL
Open market or private sale
$7,143 $31.75 p/Share
225 Reduced 0.45%
49,966 Common Stock
May 23 2025
SELL
Open market or private sale
$23,265 $27.73 p/Share
839 Reduced 1.64%
50,191 Common Stock
May 21 2025
SELL
Open market or private sale
$7,199 $29.75 p/Share
242 Reduced 0.47%
51,030 Common Stock
May 05 2025
SELL
Open market or private sale
$6,099 $37.65 p/Share
162 Reduced 0.31%
51,272 Common Stock
Mar 06 2025
SELL
Open market or private sale
$9,859 $40.91 p/Share
241 Reduced 0.47%
51,434 Common Stock
Feb 24 2025
SELL
Open market or private sale
$38,206 $41.71 p/Share
916 Reduced 1.74%
51,675 Common Stock
Feb 21 2025
SELL
Open market or private sale
$11,796 $44.18 p/Share
267 Reduced 0.51%
52,591 Common Stock
Feb 03 2025
SELL
Open market or private sale
$9,129 $49.35 p/Share
185 Reduced 0.35%
52,858 Common Stock
Dec 06 2024
SELL
Open market or private sale
$11,910 $52.7 p/Share
226 Reduced 0.42%
53,043 Common Stock
Dec 04 2024
BUY
Grant, award, or other acquisition
-
8,438 Added 13.67%
53,269 Common Stock
Nov 25 2024
SELL
Open market or private sale
$34,873 $44.2 p/Share
789 Reduced 1.73%
44,831 Common Stock
Nov 06 2024
SELL
Open market or private sale
$64,580 $44.6 p/Share
1,448 Reduced 3.08%
45,620 Common Stock
Nov 04 2024
SELL
Open market or private sale
$6,483 $41.56 p/Share
156 Reduced 0.33%
47,068 Common Stock
Nov 04 2024
BUY
Grant, award, or other acquisition
-
8,500 Added 15.25%
47,224 Common Stock
Sep 06 2024
SELL
Open market or private sale
$9,398 $39.16 p/Share
240 Reduced 0.62%
38,724 Common Stock
Aug 23 2024
SELL
Open market or private sale
$35,072 $43.14 p/Share
813 Reduced 2.04%
38,964 Common Stock
Aug 05 2024
SELL
Open market or private sale
$6,708 $39.93 p/Share
168 Reduced 0.42%
39,777 Common Stock
Jun 06 2024
SELL
Open market or private sale
$12,421 $51.33 p/Share
242 Reduced 0.6%
39,945 Common Stock
May 23 2024
SELL
Open market or private sale
$142,237 $42.32 p/Share
3,361 Reduced 7.72%
40,187 Common Stock
May 03 2024
SELL
Open market or private sale
$4,901 $37.13 p/Share
132 Reduced 0.3%
43,548 Common Stock
Mar 06 2024
SELL
Open market or private sale
$6,774 $37.43 p/Share
181 Reduced 0.41%
43,680 Common Stock

Also insider at

NVTA
Invitae Corp Healthcare
RFW

Robert F. Werner

Chief Accounting Officer
San Francisco, CA

Track Institutional and Insider Activities on TWST

Follow Twist Bioscience Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TWST shares.

Notify only if

Insider Trading

Get notified when an Twist Bioscience Corp insider buys or sells TWST shares.

Notify only if

News

Receive news related to Twist Bioscience Corp

Track Activities on TWST